BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 9103386)

  • 1. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
    Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
    Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
    Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW; Svoboda-Newman SM; Frank TS
    Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).
    Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG
    Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma.
    Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT
    Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
    Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
    J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation.
    Kataoka A; Nishida T; Sugiyama T; Hori K; Honda S; Yakushiji M
    Gynecol Oncol; 1997 Apr; 65(1):180-4. PubMed ID: 9103411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
    Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
    Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters.
    Tenti P; Zappatore R; Romagnoli S; Civardi E; Giunta P; Scelsi R; Stella G; Carnevali L
    J Pathol; 1996 Jan; 178(1):65-70. PubMed ID: 8778319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
    Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
    Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
    Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
    Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.